Dr. Peter Carson, M.D

Specialist Washington, DC Male
NPI: 1588755227
Total Payments
$909,377
2024 Payments
$25,150
Companies
15
Transactions
537

Payment Breakdown by Category

Consulting$790,533 (86.9%)
Travel$90,627 (10.0%)
Research$12,700 (1.4%)
Other$7,910 (0.9%)
Food & Beverage$7,607 (0.8%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $790,533 334 86.9%
Travel and Lodging $90,627 89 10.0%
Unspecified $12,700 10 1.4%
Honoraria $7,910 2 0.9%
Food and Beverage $7,607 102 0.8%

Payments by Type

General
$896,677
527 transactions
Research
$12,700
10 transactions

Top Paying Companies

Company Total Records Latest Year
Boehringer Ingelheim International GmbH $524,179 154 $0 (2022)
Abbott Laboratories $124,139 185 $0 (2018)
ABBVIE INC. $97,618 84 $0 (2024)
LivaNova USA, Inc. $63,635 55 $0 (2023)
Impulse Dynamics (USA) Inc. $51,810 17 $0 (2024)
Respicardia, Inc. $15,289 4 $0 (2017)
Boehringer Ingelheim Canada Ltd.Ltee $11,493 9 $0 (2020)
Novartis Pharmaceuticals Corporation $11,074 7 $0 (2020)
Merck Sharp & Dohme Corporation $6,702 7 $0 (2019)
Currax Pharmaceuticals LLC $1,750 2 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $25,150 18 ABBVIE INC. ($12,150)
2023 $52,963 28 Impulse Dynamics (USA) Inc. ($26,213)
2022 $53,177 34 LivaNova USA, Inc. ($20,980)
2021 $136,355 51 Boehringer Ingelheim International GmbH ($102,125)
2020 $418,191 124 Boehringer Ingelheim International GmbH ($397,603)
2019 $33,406 60 AbbVie, Inc. ($16,168)
2018 $104,301 107 Abbott Laboratories ($64,933)
2017 $85,834 115 Abbott Laboratories ($59,206)

All Payment Transactions

537 individual payment records from CMS Open Payments — Page 1 of 22

Date Company Product Nature Form Amount Type
11/05/2024 ABBVIE INC. RINVOQ (Biological) Consulting Fee Cash or cash equivalent $600.00 General
Category: IMMUNOLOGY
10/17/2024 ABBVIE INC. RINVOQ (Biological) Consulting Fee Cash or cash equivalent $900.00 General
Category: IMMUNOLOGY
10/17/2024 Currax Pharmaceuticals LLC CONTRAVE (Drug) — Cash or cash equivalent $500.00 Research
Study: NB (Contrave) Cardiovascular Outcomes Trial • Category: Obesity
09/17/2024 Impulse Dynamics (USA) Inc. Optimizer (Device), Optimizer Honoraria Cash or cash equivalent $1,800.00 General
Category: Cardiovascular Device
09/11/2024 ABBVIE INC. RINVOQ (Biological) Consulting Fee Cash or cash equivalent $1,200.00 General
Category: IMMUNOLOGY
08/20/2024 ABBVIE INC. RINVOQ (Biological) Consulting Fee Cash or cash equivalent $900.00 General
Category: IMMUNOLOGY
07/17/2024 ABBVIE INC. RINVOQ (Biological) Consulting Fee Cash or cash equivalent $600.00 General
Category: IMMUNOLOGY
07/10/2024 ABBVIE INC. RINVOQ (Biological) Consulting Fee Cash or cash equivalent $1,200.00 General
Category: IMMUNOLOGY
07/10/2024 ABBVIE INC. RINVOQ (Biological) Consulting Fee Cash or cash equivalent $900.00 General
Category: IMMUNOLOGY
05/29/2024 Impulse Dynamics (USA) Inc. Optimizer (Device), Optimizer Consulting Fee Cash or cash equivalent $4,500.00 General
Category: Cardiovascular Device
04/25/2024 ABBVIE INC. RINVOQ (Biological) Consulting Fee Cash or cash equivalent $900.00 General
Category: IMMUNOLOGY
03/26/2024 ABBVIE INC. RINVOQ (Biological) Consulting Fee Cash or cash equivalent $1,500.00 General
Category: IMMUNOLOGY
03/14/2024 Currax Pharmaceuticals LLC CONTRAVE (Drug) — Cash or cash equivalent $1,250.00 Research
Study: NB (Contrave) Cardiovascular Outcomes Trial • Category: Obesity
02/19/2024 ABBVIE INC. RINVOQ (Biological) Consulting Fee Cash or cash equivalent $750.00 General
Category: IMMUNOLOGY
01/12/2024 Impulse Dynamics (USA) Inc. Optimizer (Device), Optimizer Consulting Fee Cash or cash equivalent $4,950.00 General
Category: Cardiovascular Device
01/09/2024 ABBVIE INC. RINVOQ (Biological) Consulting Fee Cash or cash equivalent $900.00 General
Category: IMMUNOLOGY
01/09/2024 ABBVIE INC. RINVOQ (Biological) Consulting Fee Cash or cash equivalent $600.00 General
Category: IMMUNOLOGY
01/05/2024 ABBVIE INC. RINVOQ (Biological) Consulting Fee Cash or cash equivalent $1,200.00 General
Category: IMMUNOLOGY
11/21/2023 AbbVie Inc. RINVOQ (Biological) Consulting Fee Cash or cash equivalent $1,800.00 General
Category: IMMUNOLOGY
10/11/2023 AbbVie Inc. RINVOQ (Biological) Consulting Fee Cash or cash equivalent $1,500.00 General
Category: IMMUNOLOGY
09/21/2023 Impulse Dynamics (USA) Inc. OPTIMIZER (Device), OPTIMIZER Consulting Fee Cash or cash equivalent $4,950.00 General
Category: Cardiovascular Device
08/22/2023 AbbVie Inc. RINVOQ (Biological) Consulting Fee Cash or cash equivalent $2,400.00 General
Category: IMMUNOLOGY
07/17/2023 LivaNova USA, Inc. VNS - Vitaria (Device) Consulting Fee Cash or cash equivalent $1,400.00 General
Category: Cardiology/Vascular Diseases
07/06/2023 AbbVie Inc. RINVOQ (Biological) Consulting Fee Cash or cash equivalent $1,500.00 General
Category: IMMUNOLOGY
06/22/2023 AbbVie Inc. RINVOQ (Biological) Consulting Fee Cash or cash equivalent $3,000.00 General
Category: IMMUNOLOGY
123…22»

Research Studies & Clinical Trials

Study Name Company Amount Records
NB (Contrave) Cardiovascular Outcomes Trial Currax Pharmaceuticals LLC $1,750 2

About Dr. Peter Carson, M.D

Dr. Peter Carson, M.D is a Specialist healthcare provider based in Washington, District of Columbia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1588755227.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Carson, M.D has received a total of $909,377 in payments from pharmaceutical and medical device companies, with $25,150 received in 2024. These payments were reported across 537 transactions from 15 companies. The most common payment nature is "Consulting Fee" ($790,533).

Practice Information

  • Specialty Specialist
  • Location Washington, DC
  • Active Since 09/27/2006
  • Last Updated 07/08/2007
  • Taxonomy Code 174400000X
  • Entity Type Individual
  • NPI Number 1588755227

Products in Payments

  • JARDIANCE (Drug) $533,671
  • CardioMEMS HF System (Device) $122,386
  • RINVOQ (Biological) $45,600
  • VNS - Vitaria (Device) $44,560
  • OPTIMIZER (Device) $26,213
  • Optimizer (Device) $24,197
  • VNS Therapy (Device) $19,075
  • remede System (Device) $15,289
  • SERELAXIN (Drug) $9,913
  • Cardiovascular- Research only (Device) $1,753
  • CONTRAVE (Drug) $1,750
  • Optimizer Smart System (Device) $1,400
  • TRADJENTA (Drug) $1,375
  • ENTRESTO (Drug) $1,161
  • Carto 3 System (Device) $141.95
  • SAMSCA (Drug) $120.52
  • Veltassa (Drug) $101.04

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Specialist Doctors in Washington

Pan Zheng, Md, MD

Specialist — Payments: $2.4M

Specialist $2.4M

Dr. Gary Mintz, Md, MD

Specialist — Payments: $501,407

Specialist $501,407

Deepa Subramaniam, M.d, M.D

Specialist — Payments: $247,175

Specialist $247,175

Michael Pishvaian, Md, MD

Specialist — Payments: $185,381

Specialist $185,381

Tricia Ting, M.d, M.D

Specialist — Payments: $161,677

Specialist $161,677

Dr. Wanda Minnis-Dyson, M.d, M.D

Specialist — Payments: $29,107

Specialist $29,107